Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer.

[1]  U. Capitanio,et al.  Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma. , 2018, European urology.

[2]  Jeffrey A. Cadeddu,et al.  Renal Mass and Localized Renal Cancer: AUA Guideline , 2017, The Journal of urology.

[3]  B. Lane,et al.  Collaborative Review of Risk Benefit Trade-offs Between Partial and Radical Nephrectomy in the Management of Anatomically Complex Renal Masses. , 2017, European urology.

[4]  Xunbo Jin,et al.  Partial nephrectomy vs. radical nephrectomy for renal tumors: A meta-analysis of renal function and cardiovascular outcomes. , 2016, Urologic oncology.

[5]  B. Lane,et al.  Proteinuria is a Predictor of Renal Functional Decline in Patients with Kidney Cancer. , 2016, The Journal of urology.

[6]  B. Lane,et al.  Impact of Reduced Glomerular Filtration Rate and Proteinuria on Overall Survival of Patients with Renal Cancer. , 2016, The Journal of urology.

[7]  J. Townend,et al.  Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors , 2016, Hypertension.

[8]  Umberto Capitanio,et al.  Renal Cancer , 2011 .

[9]  A. Finelli,et al.  Partial nephrectomy for the treatment of renal cell carcinoma (RCC) and the risk of end‐stage renal disease (ESRD) , 2015, BJU international.

[10]  U. Capitanio,et al.  Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. , 2015, European urology.

[11]  A. Danser,et al.  Hypertension Renin–Angiotensin–Aldosterone System Alterations , 2015 .

[12]  A. Vickers,et al.  Guidelines for reporting of statistics in European Urology. , 2015, European urology.

[13]  F. Dekker,et al.  Long-term risks for kidney donors. , 2014, Kidney international.

[14]  E. Messing,et al.  Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. , 2014, European urology.

[15]  E. Messing,et al.  Radical versus partial nephrectomy for a small renal mass: does saving nephrons save lives? , 2013, Expert review of anticancer therapy.

[16]  V. Janevska,et al.  S153 Partial nephrectomy may protect from future cardiovascular disease-first experimental evidence , 2013 .

[17]  J. Pluznick.  Renal and cardiovascular sensory receptors and blood pressure regulation. , 2013, American journal of physiology. Renal physiology.

[18]  K. Kihara,et al.  Impact of renal function on cardiovascular events in patients undergoing radical nephrectomy for renal cancer , 2012, International journal of urology : official journal of the Japanese Urological Association.

[19]  N. Pallet,et al.  Very long‐term follow‐up of living kidney donors , 2012, Transplant international : official journal of the European Society for Organ Transplantation.

[20]  M. Carini,et al.  Elective partial nephrectomy is equivalent to radical nephrectomy in patients with clinical T1 renal cell carcinoma: results of a retrospective, comparative, multi‐institutional study , 2012, BJU international.

[21]  U. Capitanio,et al.  A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma. , 2010, Urology.

[22]  Lorenzo Marconi,et al.  EAU guidelines on renal cell carcinoma: 2014 update. , 2010, European urology.

[23]  Jihad H Kaouk,et al.  Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. , 2010, The Journal of urology.

[24]  F. Saad,et al.  Radical versus partial nephrectomy , 2009, Cancer.

[25]  J. Patard,et al.  Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study. , 2008, Urology.

[26]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[27]  G. London,et al.  Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  J. Blacher,et al.  Aortic pulse wave velocity index and mortality in end-stage renal disease. , 2003, Kidney international.

[29]  B. Psaty,et al.  Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency , 2003, Circulation.

[30]  C. McCulloch,et al.  Iron status and hemoglobin level in chronic renal insufficiency. , 2002, Journal of the American Society of Nephrology : JASN.

[31]  P. Raggi,et al.  Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? , 2002, Journal of the American College of Cardiology.

[32]  J Singer,et al.  Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  M. Stenbeck,et al.  Kidney donors live longer. , 1997, Transplantation.

[34]  C. Porta,et al.  Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  R. Sylvester,et al.  A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. , 2011, European urology.

[36]  Paul Russo,et al.  Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? , 2009, The Journal of urology.

[37]  Lorenzo Marconi,et al.  Guidelines on Renal Cell Carcinoma , 2007 .

[38]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.